期刊
FERTILITY AND STERILITY
卷 108, 期 5, 页码 742-747出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2017.10.007
关键词
implantation; mitochondrial DNA; embryo viability
资金
- National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme
- Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD092550]
Of all the factors currently available for the evaluation of embryonic potential, chromosomal status appears to be the most definitive. The debate around this hotly contested issue does not focus on the question of whether aneuploidy is detrimental to development, but on whether current preimplantation genetic testing for aneuploidy methods are capable of accurately determining whether an embryo is chromosomally normal, aneuploid or a mixture of normal and abnormal cells (i.e., mosaic). Despite the importance of aneuploidy, it is clear that this is only one factor amongst many of relevance to embryo viability, as evidenced by the fact that even the transfer of a chromosomally normal embryo cannot guarantee a pregnancy. Mounting evidence supports the hypothesis that blastocysts having unusually high levels of mitochondrial DNA detected in the trophectoderm have greatly reduced implantation potential, but there remain significant areas where further validation is necessary and where our understanding is currently inadequate. This should provide fertile ground for future research and is likely to yield some fascinating insights in the coming years. (C)2017 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据